This is supported by the findings about a significant reduction in TIGIT-expressing NK cells in patients with SLE with respect to controls, which were negatively correlated with disease activity and that TIGIT+ NK cells presented a considerably reduced functional potential compared with TIGIT− NK cells. The gene discussed is TIGIT; the disease is systemic lupus erythematosus.